Search For "biotech"
Bharat Biotech denies receiving advance payments, supplying vaccines to Br
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], June 30 (ANI): Issuing clarification on COVAXIN pricing controversy in Brazil, Bharat Biotech on Tuesday said it followed a step-by-step regulatory approval process during the eight-month period, but the company has neither received any advance payments nor
Read More
Covaxin effectively neutralises both Alpha, Delta variants of Covid-19: US
Updated : 4 years, 8 months ago IST
Washington DC [US], June 30 (ANI): The National Institute of Health (NIH) in the United States has found that Bharat Biotech's COVAXIN vaccine generates antibodies that effectively neutralize both Alpha and Delta variants of COVID-19.
Read More
Brazil to suspend Covaxin vaccine deal
Updated : 4 years, 8 months ago IST
Brasilia [Brazil], June 30 (ANI): Amid a probe into accusations of irregularities against President Jair Bolsonaro, Brazil's health minister has announced that the country will suspend a USD 324 million contract to buy 20 million doses of Bharat Biotech's Covaxin.
Read More
Moderna's COVID-19 vaccine granted emergency use nod in India
Updated : 4 years, 8 months ago IST
Cambridge [UK]/New Delhi, June 29 (ANI): US biotechnology company Moderna on Tuesday announced that India has granted permission for its COVID-19 vaccine to be imported into the country for restricted use in an emergency situation.
Read More
Union Minister Mansukh Mandaviya reviews COVID-19 vaccines production in H
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], June 27 (ANI): Union Minister of State for Chemicals and Fertilisers Mansukh Mandaviya along with Minister of State for Home Affairs G Kishan Reddy on Sunday reviewed production of COVID-19 vaccines in Hyderabad.
Read More
India likely to have COVID vaccine for children above 2 years by September
Updated : 4 years, 8 months ago IST
New Delhi [India], June 23 (ANI): Noting that children usually have a mild disease but there is a need to develop COVID-19 vaccines for them, AIIMS Delhi Director Dr Randeep Guleria has said Bharat Biotech and other companies are doing trials at a very fast pace and hoped that data will l
Read More
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Read More
Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III trials, say s
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.
Read More
DCGI's expert panel to review Phase III data of Covaxin today
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat Biotech's Covaxin on Tuesday.
Read More
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt
Updated : 4 years, 8 months ago IST
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Read More
SENSIT rapid COVID-19 Ag exhibits 86 pc sensitivity, 100 pc specificity
Updated : 4 years, 9 months ago IST
New Delhi [India], June 19 (ANI): The SENSIT rapid COVID-19 Ag Kit, developed by Ubio Biotechnology Systems Pvt. Ltd and supported by DBT-BIRAC under the aegis of COVID-19 Research Consortium, exhibit sensitivity and specificity of 86 per cent and 100 per cent, according to the Ministry of S
Read More
Bharat Biotech, WHO pre-submission meeting on June 23: WHO
Updated : 4 years, 9 months ago IST
New Delhi [India], June 17 (ANI): Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use Listing (EUL) of its indigenous COVID-19 vaccine Covaxin.
Read More